Difference between revisions of "Team:ASIJ Tokyo"
| Line 21: | Line 21: | ||
position: absolute; | position: absolute; | ||
top: 150px; | top: 150px; | ||
| − | left: | + | left: 600px; |
font-weight: bold; | font-weight: bold; | ||
font-family: "Avenir"; | font-family: "Avenir"; | ||
| Line 66: | Line 66: | ||
<div id="abstract"> | <div id="abstract"> | ||
<h3> ABSTRACT </h3> | <h3> ABSTRACT </h3> | ||
| − | <p> Alpha-1 Antitrypsin deficiency is a common genetic disorder -- the defective gene for which is carried by 1 in 25 people -- which arises from a single base pair mutation in the SERPINA1 gene, resulting in the production of a form of antitrypsin prone to polymerization. The mutated antitrypsin then builds up in liver cells and is unable to inhibit proteases in the | + | <p> Alpha-1 Antitrypsin deficiency is a common genetic disorder -- the defective gene for which is carried by 1 in 25 people -- which arises from a single base pair mutation in the SERPINA1 gene, resulting in the production of a form of antitrypsin prone to polymerization. The mutated antitrypsin then builds up in liver cells and is unable to inhibit proteases in the lung |
| − | + | ||
| − | + | ||
| − | + | ||
Revision as of 23:01, 9 September 2018
A1-AT
deLIVERy
Using Stem Cell and CRISPR Technology to Combat
Alpha-1 Antitrypsin Deficiency
ABSTRACT
Alpha-1 Antitrypsin deficiency is a common genetic disorder -- the defective gene for which is carried by 1 in 25 people -- which arises from a single base pair mutation in the SERPINA1 gene, resulting in the production of a form of antitrypsin prone to polymerization. The mutated antitrypsin then builds up in liver cells and is unable to inhibit proteases in the lung